Epidemiology of Coronary Heart Disease in the Elderly

[1]  R. Luben,et al.  Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study. , 2007, Journal of the American College of Cardiology.

[2]  Simon Capewell,et al.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.

[3]  Michael J Pencina,et al.  Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study , 2007, Circulation.

[4]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[5]  T. Harris,et al.  Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. , 2006, The New England journal of medicine.

[6]  Nancy R Cook,et al.  The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.

[7]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[8]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[9]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[10]  J. McNeil,et al.  Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. , 2006, Journal of the American College of Cardiology.

[11]  J. Murabito,et al.  Cardiovascular Risk Factors Predictive for Survival and Morbidity‐Free Survival in the Oldest‐Old Framingham Heart Study Participants , 2005, Journal of the American Geriatrics Society.

[12]  D. Levy,et al.  Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). , 2005, The American journal of cardiology.

[13]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[14]  D. Levy,et al.  Temporal Trends in Coronary Heart Disease Mortality and Sudden Cardiac Death From 1950 to 1999: The Framingham Heart Study , 2004, Circulation.

[15]  D. Levy,et al.  Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women: The Framingham Heart Study , 2004, Hypertension.

[16]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[17]  Wolfgang Reuter,et al.  Circulating Vascular Cell Adhesion Molecules VCAM-1, ICAM-1, and E-Selectin in Dependence on Aging , 2003, Gerontology.

[18]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[19]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[20]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[21]  W. Haynes.  Hyperhomocysteinemia, Vascular Function and Atherosclerosis: Effects of Vitamins , 2002, Cardiovascular Drugs and Therapy.

[22]  D. Levy,et al.  Impact of age and sex on plasma natriuretic peptide levels in healthy adults. , 2002, The American journal of cardiology.

[23]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[24]  M. Nieminen,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[25]  G. Lowe,et al.  Fibrinogen and Its Degradation Products as Thrombotic Risk Factors , 2001, Annals of the New York Academy of Sciences.

[26]  T. Hedner,et al.  Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension–2 , 2000, Journal of hypertension.

[27]  H. Rubins.  Triglycerides and Coronary Heart Disease: Implications of Recent Clinical Trials , 2000, Journal of cardiovascular risk.

[28]  R. D'Agostino,et al.  Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study , 1999, Annals of Internal Medicine.

[29]  R. Collins,et al.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.

[30]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[31]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[32]  O. Faergeman,et al.  Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S) , 1997, Circulation.

[33]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[34]  L. Ferrucci,et al.  Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons , 1997, Annals of Internal Medicine.

[35]  A. Mushlin,et al.  Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. , 1996, Annals of internal medicine.

[36]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[37]  Alan Garber,et al.  CLINICAL GUIDELINE, PART 2: Cholesterol Screening in Asymptomatic Adults, Revisited , 1996, Annals of Internal Medicine.

[38]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[39]  R. Glynn,et al.  HDL cholesterol predicts coronary heart disease mortality in older persons. , 1995, JAMA.

[40]  G. Levine,et al.  Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. , 1995, The New England journal of medicine.

[41]  S. Hulley,et al.  Cholesterol in the elderly. Is it important? , 1994, JAMA.

[42]  J. E. Pedersen,et al.  Inhalation of levomepromazine in severe acute asthma , 1994, The Lancet.

[43]  D. Levy,et al.  Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. , 1994, Circulation.

[44]  J. Muller,et al.  Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. , 1994, Journal of the American College of Cardiology.

[45]  R S Paffenbarger,et al.  The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. , 1993, The New England journal of medicine.

[46]  S. Yusuf,et al.  Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.

[47]  José Luis Bernal,et al.  Management of acute myocardial infarction in the very elderly. , 1992, The American journal of medicine.

[48]  W. Koenig,et al.  Plasma viscosity as a cardiovascular risk factor. , 1992, Circulation.

[49]  W. Aronow.  Left Ventricular Hypertrophy , 1992, Journal of the American Geriatrics Society.

[50]  B. Dahlöf,et al.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) , 1991, The Lancet.

[51]  P. Wilson,et al.  Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. , 1991, Annals of internal medicine.

[52]  D. Reed,et al.  Does cigarette smoking have an independent effect on coronary heart disease incidence in the elderly? , 1991, American journal of public health.

[53]  A. LaCroix,et al.  Smoking and mortality among older men and women in three communities. , 1991, The New England journal of medicine.

[54]  Y. Friedlander,et al.  The Dubbo Study of the Health of Elderly: Correlates of Coronary Heart Disease at Study Entry , 1991, Journal of the American Geriatrics Society.

[55]  P. Wilson,et al.  Is hyperglycemia associated with cardiovascular disease? The Framingham Study. , 1991, American heart journal.

[56]  M. Hong,et al.  Total cholesterol/HDL ratio is the best predictor of anatomic coronary artery disease among elderly patients , 1991 .

[57]  W. Kannel,et al.  Parental history is an independent risk factor for coronary artery disease: the Framingham Study. , 1990, American heart journal.

[58]  G A Colditz,et al.  A meta-analysis of physical activity in the prevention of coronary heart disease. , 1990, American journal of epidemiology.

[59]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[60]  A J Dobson,et al.  On the use of a logistic risk score in predicting risk of coronary heart disease. , 1990, Statistics in medicine.

[61]  B Rosner,et al.  A prospective study of obesity and risk of coronary heart disease in women. , 1990, The New England journal of medicine.

[62]  D. Reed,et al.  Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? , 1990, JAMA.

[63]  D. Levy,et al.  Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study. , 1989, American journal of epidemiology.

[64]  W. Applegate.  Hypertension in elderly patients. , 1989, Annals of internal medicine.

[65]  W. Aronow,et al.  41‐Month Follow‐Up of Risk Factors Correlated With New Coronary Events in 708 Elderly Patients , 1989, Journal of the American Geriatrics Society.

[66]  D. Levy,et al.  Cardiovascular risk factors in the elderly. , 1989, The American journal of cardiology.

[67]  D. Levy,et al.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.

[68]  W. Kannel,et al.  Proportional Hazards Analysis of Risk Factors for Coronary Heart Disease in Individuals Aged 65 or Older , 1988, Journal of the American Geriatrics Society.

[69]  D. Malenka,et al.  Cholesterol and coronary heart disease. The importance of patient-specific attributable risk. , 1988, Archives of internal medicine.

[70]  D. Reed,et al.  Physical activity and coronary heart disease in middle-aged and elderly men: the Honolulu Heart Program. , 1988, American journal of public health.

[71]  W. Aronow,et al.  Usefulness of echocardiographic left ventricular hypertrophy in predicting new coronary events and atherothrombotic brain infarction in patients over 62 years of age. , 1988, The American journal of cardiology.

[72]  D. Levy,et al.  Population implications of electrocardiographic left ventricular hypertrophy. , 1987, The American journal of cardiology.

[73]  S. Strandgaard,et al.  WHY DOES ANTIHYPERTENSIVE TREATMENT PREVENT STROKE BUT NOT MYOCARDIAL INFARCTION? , 1987, The Lancet.

[74]  P. Vokonas,et al.  Prevention of cardiovascular disease in the elderly. , 1987, Journal of the American College of Cardiology.

[75]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[76]  E. Eaker,et al.  Psychosocial and other features of coronary heart disease: insights from the Framingham Study. , 1986, American heart journal.

[77]  R. D'Agostino,et al.  Physical activity and physical demand on the job and risk of cardiovascular disease and death: the Framingham Study. , 1986, American heart journal.

[78]  P. Vokonas,et al.  Body weight and coronary disease risk: patterns of risk factor change associated with long-term weight change. The Normative Aging Study. , 1986, American journal of epidemiology.

[79]  A P Avolio,et al.  Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. , 1985, Circulation.

[80]  W. Kannel,et al.  Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.

[81]  W. Kannel,et al.  Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application. , 1982, American heart journal.

[82]  Ralph A. DeFronzo.  Glucose Intolerance and Aging , 1981, Diabetes Care.

[83]  Daniel L. McGee,et al.  Blood pressure and survival after myocardial infarction: the Framingham study. , 1980, The American journal of cardiology.

[84]  W. Kannel,et al.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. , 1970, Annals of internal medicine.

[85]  M. Pfeffer,et al.  Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. , 2007, Journal of the American College of Cardiology.

[86]  W. Aronow.  Managing Hyperlipidaemia in the Elderly , 2006, Drugs & aging.

[87]  M. Rich.  Epidemiology, clinical features, and prognosis of acute myocardial infarction in the elderly. , 2006, The American journal of geriatric cardiology.

[88]  Sudha Seshadri,et al.  Antecedent Blood Pressure and Risk of Cardiovascular Disease: The Framingham Heart Study , 2002, Circulation.

[89]  J. Fleg,et al.  Cholesterol as a risk factor for coronary heart disease in elderly men. The Baltimore Longitudinal Study of Aging. , 1992, Annals of epidemiology.

[90]  T. Manolio,et al.  Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. , 1992, Annals of epidemiology.

[91]  D. Levy,et al.  Lipids and risk of coronary heart disease. The Framingham Study. , 1992, Annals of epidemiology.

[92]  P. Vokonas,et al.  Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. , 1992, Annals of epidemiology.

[93]  W. Applegate,et al.  Case-control study of coronary heart disease risk factors in the elderly. , 1991, Journal of clinical epidemiology.

[94]  R J Glynn,et al.  White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. , 1990, Journal of clinical epidemiology.

[95]  R B D'Agostino,et al.  Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. , 1988, Statistics in medicine.

[96]  W. Kannel,et al.  Atheroschlerosis risk factors , 1987 .

[97]  E. Barrett-Connor,et al.  Ischemic heart disease risk factors after age 50. , 1984, Journal of chronic diseases.

[98]  M. Mathan,et al.  Letter: Orbiviruses and gastroenteritis. , 1974, Lancet.

[99]  R. O'rourke,et al.  Update: Systemic Diseases and the Cardiovascular System (VII) Cardiovascular Disease in the Elderly , 2022 .